Andoni Echaniz‐Laguna

Author

Also Known As

A Echaniz-Laguna, A. Echaniz-Laguna, A. Echaniz‐Laguna, Andoni ECHANIZ-LAGUNA, Andoni Echaniz-Laguna, Andoni Echaniz-Laguna (372972), Andoni Echaniz‐Laguna, C Dornonville de la Cour, Claude Desnuelle, Echaniz-Laguna, A.

302

Publications

7.7K

Citations

H-Index

138

Concepts

All Affiliations

Inserm Université de Strasbourg Hôpitaux Universitaires de Strasbourg Sorbonne Université Assistance Publique – Hôpitaux de Paris

About

Andoni Echaniz‐Laguna is an author at Inserm specializing in medicine, neurology, and neuropathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	46	2.5K
2	Health Sciences	9	9	540
3	Public Health	3	4	261
4	Engineering	1	1	69
5	Natural Sciences	1	1	34

Andoni Echaniz‐Laguna

115

Publications

6.3K

Citations

H-Index

Page 1

	Year	Citations
Opposite effects of statins on mitochondria of cardiac and skeletal muscles: a ‘mitohormesis’ mechanism involving reactive oxygen species and PGC-1 Jamal Bouitbir, Anne‐Laure Charles, Andoni Echaniz‐Laguna, European Heart Journal	2011	247
Development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies Karim Wahbi, Rabah Ben Yaou, Estelle Gandjbakhch, Circulation	2019	245
A metabolic switch toward lipid use in glycolytic muscle is an early pathologic event in a mouse model of amyotrophic lateral sclerosis Lavinia Palamiuc, A. Schlagowski, Shyuan T. Ngo, EMBO Molecular Medicine Metabolic SyndromeEnergy MetabolismLipid UseAmyotrophic Lateral SclerosisLipid Metabolism	2015	224
Sodium Valproate Exerts Neuroprotective Effects<i>In Vivo</i>through CREB-Binding Protein-Dependent Mechanisms But Does Not Improve Survival in an Amyotrophic Lateral Sclerosis Mouse Model Caroline Rouaux, Irina Panteleeva, Frédérique René, Journal of Neuroscience	2007	209
Muscle Mitochondrial Uncoupling Dismantles Neuromuscular Junction and Triggers Distal Degeneration of Motor Neurons Luc Dupuis, José‐Luis González de Aguilar, Andoni Echaniz‐Laguna, PLoS ONE	2009	194
Natural History, Phenotypic Spectrum, and Discriminative Features of Multisystemic RFC1 Disease Andreas Traschütz, Andrea Cortese, Selina Reich, Neurology	2021	159
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study David Adams, Michael Polydefkis, Alejandra González‐Duarte, The Lancet Neurology Alzheimer's DiseaseOpen-label Extension StudyMedicineHereditary Transthyretin-mediated AmyloidosisNeurology	2020	154
Mutation spectrum in the large GTPase dynamin 2, and genotype-phenotype correlation in autosomal dominant centronuclear myopathy Johann Böhm, Valérie Biancalana, Elizabeth T. DeChene, Human Mutation Peripheral NeuropathyMendelian DisorderAutoimmune DiseaseSkeletal MuscleGenetic Disorder	2012	135
Myoclonus–dystonia Emmanuel Roze, Emmanuelle Apartis, F. Clot, Neurology	2008	130
Defects in amphiphysin 2 (BIN1) and triads in several forms of centronuclear myopathies Anne Toussaint, Belinda S. Cowling, Karim Hnia, Acta Neuropathologica ChromatinGeneticsMolecular BiologyMolecular GeneticsCentronuclear Myopathies	2010	129

Page 1